| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.1M | — | +80.3% |
| R&D Expense | $1.4M | — | +0.0% |
| SG&A Expense | $6.5M | — | +0.9% |
| Operating Income | -$6.4M | — | +33.1% |
| Pre-tax Income | -$118.3M | — | -271.1% |
| Income Tax | $40K | — | -94.4% |
| Net Income | -$118.3M | — | -263.1% |
| EPS (Basic) | -$0.84 | — | -147.1% |
| EPS (Diluted) | -$0.84 | — | -147.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $121.9M | +29.1% | +588.0% |
| Accounts Receivable | $10.0M | +16.6% | +453.9% |
| Inventory | $2.4M | +12.9% | — |
| Current Assets | $144.5M | +25.5% | +499.8% |
| Total Assets | $188.1M | +24.3% | +206.3% |
| Current Liabilities | $59.1M | +162.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $158K | — | +103.3% |
| Capital Expenditures | $5.5M | — | +190.1% |
| Investing Cash Flow | -$5.5M | — | -190.1% |
| Financing Cash Flow | $32.5M | — | +1830.1% |
| Free Cash Flow | -$5.4M | — | +18.7% |
| +42.1% |
| Total Liabilities | $213.6M | +135.3% | +47.8% |
| Stockholders' Equity | -$25.5M | -142.2% | +69.3% |